Plasma Lipocalin 2 in Alzheimer's disease: potential utility in the differential diagnosis and relationship with other biomarkers.

Peter HermannAnna Villar-PiquéMatthias SchmitzChristian SchmidtDaniela VargesStefan GoebelTimothy BunckHanna LindemannCarla BognerIsabel SantanaInês BaldeirasJoachim RiggertInga ZerrFranc Llorens

Published in: Alzheimer's research & therapy (2022)

Plasma Lipocalin-2 has potential as a diagnostic biomarker for Alzheimer's disease and seems to be independent from currently employed biomarkers.

Keyphrases

cognitive decline
climate change